Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06383806 · ClinicalTrials.gov registry record · NA
Decreasing Nightmares in Adults With Narcolepsy
A NA study, sponsored by University of Utah.
- Not yet
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT06383806: Clinical Trial NA study, sponsored by University of Utah.
NCT06383806 is a NA study that has not yet begun recruiting, run by University of Utah. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06383806, a NA study, has not yet begun recruiting, sponsored by University of Utah.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
The purpose of this clinical trial is learn whether a behavioral (non-medication) treatment can reduce nightmares in adults with narcolepsy. All participants will receive the treatment and will complete three assessments. Half of the participants will receive the treatment after the first assessment, and half will receive it after the second assessment. Romantic partners of participants with narcolepsy will also be eligible to enroll in the study. Partners will complete three assessments but will not participate in the treatment.
Primary Outcome
The DDNSI is a questionnaire which measures the severity of nightmares.
Interventions
- BEHAVIORAL Imagery Rehearsal Therapy (IRT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2026-04-01 |
| Est. Completion | 2027-09 |
| Phase | NA |
What is known before NCT06383806 opens enrollment
NCT06383806 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 1 intervention - of which Imagery Rehearsal Therapy (IRT) is the first listed.
NCT06383806 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06383806 about?
NCT06383806 is a clinical study titled "Decreasing Nightmares in Adults With Narcolepsy". The purpose of this clinical trial is learn whether a behavioral (non-medication) treatment can reduce nightmares in adults with narcolepsy. All participants will receive the treatment and will complete three assessments. Half of the participants will receive the treatment after the first assessment...
What is the current status of trial NCT06383806?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2026-04-01. Estimated completion is 2027-09.
What interventions are being tested in trial NCT06383806?
The interventions under investigation include: Imagery Rehearsal Therapy (IRT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06383806?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06383806's enrollment target sits among peer trials
80 994th of 2000 higher than 941 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI